Condition
Liver Tumour
Total Trials
5
Recruiting
0
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 2 (2)
Trial Status
Completed3
Terminated1
Active Not Recruiting1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06579833Not ApplicableActive Not RecruitingPrimary
Histotripsy (HistoSonics®) for Liver Tumours
NCT02181075Phase 1CompletedPrimary
Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours
NCT02041065Phase 2CompletedPrimary
Waterjet Versus Ultrasound Dissection During Hepatic Transection
NCT01082419Not ApplicableCompleted
Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity
NCT01726465Phase 2Terminated
Methylprednisolone N Acetylcysteine in Hepatic Resections
Showing all 5 trials